RHO CAPITAL PARTNERS INC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 177 filers reported holding CARA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHO CAPITAL PARTNERS INC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q2 2021$21,392,000
-61.3%
1,499,058
-41.2%
1.96%
-63.2%
Q1 2021$55,340,000
+30.7%
2,549,058
-8.9%
5.32%
-76.1%
Q4 2020$42,350,000
+18.9%
2,799,0580.0%22.29%
-24.8%
Q3 2020$35,618,000
-25.6%
2,799,0580.0%29.66%
-4.3%
Q2 2020$47,864,000
+13.5%
2,799,058
-12.3%
31.00%
-27.1%
Q1 2020$42,180,000
-18.0%
3,193,0570.0%42.50%
+8.7%
Q4 2019$51,440,000
-11.9%
3,193,0570.0%39.10%
-20.0%
Q3 2019$58,369,000
-16.9%
3,193,057
-2.3%
48.88%
+0.3%
Q2 2019$70,263,000
+0.4%
3,268,057
-8.4%
48.74%
-34.2%
Q1 2019$70,005,000
+50.9%
3,568,0570.0%74.08%
+8.8%
Q4 2018$46,385,000
-45.7%
3,568,0570.0%68.07%
-13.4%
Q3 2018$85,455,000
+25.1%
3,568,0570.0%78.61%
+20.3%
Q2 2018$68,328,000
+54.7%
3,568,0570.0%65.36%
+4.9%
Q1 2018$44,173,000
+1.1%
3,568,0570.0%62.30%
-17.9%
Q4 2017$43,673,000
-10.6%
3,568,0570.0%75.90%
-1.3%
Q3 2017$48,847,000
-11.0%
3,568,0570.0%76.92%
+0.3%
Q2 2017$54,912,000
-16.3%
3,568,0570.0%76.67%
-16.9%
Q1 2017$65,617,000
+130.2%
3,568,057
+16.3%
92.21%
+322.3%
Q4 2016$28,502,000
+11.3%
3,068,0570.0%21.84%
+26.2%
Q3 2016$25,618,000
+73.6%
3,068,0570.0%17.30%
+46.6%
Q2 2016$14,757,000
-22.7%
3,068,0570.0%11.80%
+13.0%
Q1 2016$19,083,000
-57.6%
3,068,057
+15.0%
10.45%
-32.4%
Q4 2015$44,983,000
+18.0%
2,668,0570.0%15.47%
+22.1%
Q3 2015$38,127,000
+17.6%
2,668,0570.0%12.66%
+11.7%
Q2 2015$32,417,000
+20.9%
2,668,0570.0%11.34%
+1.4%
Q1 2015$26,814,000
+0.8%
2,668,0570.0%11.18%
-5.3%
Q4 2014$26,601,000
+18.8%
2,668,0570.0%11.80%
+5.0%
Q3 2014$22,385,000
-50.7%
2,668,0570.0%11.24%
-36.3%
Q2 2014$45,410,000
-8.5%
2,668,0570.0%17.64%
-9.0%
Q1 2014$49,653,0002,668,05719.38%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Chescapmanager LLC 1,304,903$20,161,0002.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 715,684$11,057,0001.34%
DISCIPLINED GROWTH INVESTORS INC /MN 1,669,089$25,787,0000.51%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 156,625$2,420,0000.37%
ALPINE WOODS CAPITAL INVESTORS, LLC 184,632$2,853,0000.30%
Campbell & CO Investment Adviser LLC 42,600$658,0000.21%
FARALLON CAPITAL MANAGEMENT LLC 2,000,000$30,900,0000.14%
PDT Partners, LLC 104,648$1,617,0000.12%
Virtus ETF Advisers LLC 14,798$229,0000.10%
PINNACLE ASSOCIATES LTD 338,922$5,236,0000.10%
View complete list of CARA THERAPEUTICS INC shareholders